CN115463177B - 一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物 - Google Patents
一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物 Download PDFInfo
- Publication number
- CN115463177B CN115463177B CN202111177024.0A CN202111177024A CN115463177B CN 115463177 B CN115463177 B CN 115463177B CN 202111177024 A CN202111177024 A CN 202111177024A CN 115463177 B CN115463177 B CN 115463177B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- raw materials
- root
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 210000003101 oviduct Anatomy 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 210000001672 ovary Anatomy 0.000 title description 4
- 208000000509 infertility Diseases 0.000 claims abstract description 29
- 230000036512 infertility Effects 0.000 claims abstract description 29
- 231100000535 infertility Toxicity 0.000 claims abstract description 29
- 210000000582 semen Anatomy 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 13
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 13
- 235000003956 Luffa Nutrition 0.000 claims abstract description 11
- 244000050983 Luffa operculata Species 0.000 claims abstract description 11
- 241000903946 Clematidis Species 0.000 claims abstract description 10
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 3
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 12
- 241000123589 Dipsacus Species 0.000 claims description 10
- 241000792859 Enema Species 0.000 claims description 10
- 239000007920 enema Substances 0.000 claims description 10
- 229940095399 enema Drugs 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 9
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 9
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000316342 Taxillus Species 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 240000007164 Salvia officinalis Species 0.000 claims description 5
- 244000178320 Vaccaria pyramidata Species 0.000 claims description 5
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 4
- 206010002659 Anovulatory cycle Diseases 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 230000000624 ovulatory effect Effects 0.000 claims description 3
- 235000017276 Salvia Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000004064 dysfunction Effects 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 206010065789 Fallopian tube obstruction Diseases 0.000 claims 1
- 208000030843 hydrosalpinx Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 208000011707 Ovulation disease Diseases 0.000 abstract description 5
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 4
- 235000011477 liquorice Nutrition 0.000 abstract description 4
- 230000002611 ovarian Effects 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 3
- 201000004535 ovarian dysfunction Diseases 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 16
- 229940079593 drug Drugs 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 12
- 241001247821 Ziziphus Species 0.000 description 11
- 230000027758 ovulation cycle Effects 0.000 description 11
- 230000001976 improved effect Effects 0.000 description 10
- 241001106477 Paeoniaceae Species 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 230000016087 ovulation Effects 0.000 description 7
- 230000035935 pregnancy Effects 0.000 description 7
- 210000000664 rectum Anatomy 0.000 description 7
- 230000005906 menstruation Effects 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 230000003325 follicular Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000003821 menstrual periods Effects 0.000 description 5
- 235000014066 European mistletoe Nutrition 0.000 description 4
- 244000152640 Rhipsalis cassutha Species 0.000 description 4
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000008217 follicular development Effects 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 235000005412 red sage Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000007984 Female Infertility Diseases 0.000 description 2
- 206010021928 Infertility female Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000002513 anti-ovulatory effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000035606 childbirth Effects 0.000 description 2
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 2
- 229960003608 clomifene Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000003359 percent control normalization Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012559 Developmental delay Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 208000019468 Iatrogenic Disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000034702 Multiple pregnancies Diseases 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000301400 Trogopterus Species 0.000 description 1
- 240000000260 Typha latifolia Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003779 heat-resistant material Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000938 luteal effect Effects 0.000 description 1
- 230000029849 luteinization Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
本发明公开了一种治疗卵巢功能低下和/或输卵管堵塞的中药组合物，它是由下述重量配比的原料制备而成：菟丝子10～20份、续断片10～20份、寄生15～20份、桂枝5～15份、大枣10～20份、白芍10～20份、甘草4～12份、威灵仙5～10份、王不留行5～10份、丝瓜络5～10份、丹参10～20份、巴戟天5～15份。本发明组合物能够促进输卵管功能的康复，提升卵巢功能，治疗排卵障碍性不孕和输卵管堵塞性不孕，收效良好，具备临床应用价值。
Description
技术领域
本发明具体涉及一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物。
背景技术
不孕症是妇科疑难疾病，世界卫生组织将不孕症列为仅次于肿瘤和心脑血管病的第三大疾病，据统计我国不孕不育的比例约18.7％,女性不孕因素占40％～45％，其中输卵管堵塞性不孕占25％～30％，排卵障碍性不孕约占25～35％，流行病学调查结果显示，排卵障碍及输卵管堵塞性不孕的发病率均呈逐年显著攀升的趋势。排卵障碍是指卵泡发育障碍或成熟后不能正常排出，目前西医促卵泡生长、发育、成熟的方法很多，临床疗效肯定，但存在诱发成熟卵泡排出的方法单一，且易并发卵泡未破裂黄体综合征、卵巢过度刺激综合征及多胎妊娠等医源性疾病。引起输卵管堵塞的因素主要有盆腔炎性疾病(PID)、子宫内膜异位症、支原体感染、盆腹腔手术史以及先天解剖异常等，这些因素导致输卵管不同程度粘连、梗阻，致其拾卵、受精、运输受精卵等功能受影响而引发不孕。西医主要通过腔镜手术、介入术、物理疗法等方法治疗输卵管堵塞性不孕，该类疗法可提高输卵管通畅率、改善粘粘，但未根本解决输卵管收缩功能和纤毛运动功能受损的问题，加之部分抗炎药会影响卵子发育，不利于精卵结合受孕，故治疗后易复发炎症、堵塞，且妊娠率较低下。
与西药比较，中药方剂在治疗排卵障碍方面，临床疗效确切，具有排卵率、妊娠率高、不良反应少的特点；在治疗输卵管堵塞方面，也具有良好效果，但目前还没有即能用于卵巢功能低下，又能用于输卵管堵塞的中药方剂的研究。
发明内容
为解决上述问题，本发明提供了一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物，它是由下述重量配比的原料制备而成：菟丝子10～20份、续断片10～20份、桑寄生15～20份、桂枝5～15份、大枣10～20份、白芍10～20份、甘草4～12份、威灵仙5～10份、王不留行5～10份、丝瓜络5～10份、丹参10～20份、巴戟天5～15份。
进一步低，它是由下述重量配比的原料制备而成：
菟丝子15份、续断片15份、桑寄生15份、桂枝10份、大枣15份、白芍15份、甘草8份、威灵仙10份、王不留行10份、丝瓜络10份、丹参15份、巴戟天10份。
更进一步地，所述菟丝子为盐菟丝子；所述甘草为炙甘草。
进一步地，它是由原料药的药粉、或原料药的水或有机溶剂提取物为活性成分，加上药品或食品上可接受的辅料制备而成的外用制剂。
更进一步地，所述外用制剂为颗粒剂、散剂、丸剂或溶液剂。
更进一步地，所述溶液剂为灌肠溶液。
本发明还提供了一种前述组合物的制备方法，它包括以下步骤：
(1)按照前述配比称取原料药；
(2)原料药研为粉末，或原料药的水或有机溶剂提取液，加入药品或食品上常用的辅料或辅助性成分，即得。
本发明还提供了一种前述的组合物在在制备治疗卵巢功能低下的药物中的用途。
本发明还提供了一种前述的组合物在制备治疗输卵管堵塞的药物中的用途。
本发明最后提供了一种前述的组合物在制备益肾固精和/或温阳通络的药物中的用途。
本发明组合物中，菟丝子补肾壮阳、益肾固精；桑寄生、巴戟天补益肝肾，三药共为君药，起补益肝肾，壮阳，固精之效。巴戟天温肾助阳，桂枝温通血脉，助阳行瘀通络；丹参、丝瓜络、王不留行、威灵仙四药相配，以活血化瘀，通络止痛为臣药。大枣配甘草，补中益气，养血安神，意在气旺则血行，瘀去则络通；白芍配甘草，酸甘化阴，养血调经，为佐使之用。诸药相配，共奏益肾固精，温阳通络之效。
本发明组合物制成的灌肠液，通过直肠吸收，避免了肝肠循环，疗效快，副作用少，经临床试验证明，本发明组合物能够促进输卵管功能的康复，提升卵巢功能，治疗排卵障碍性不孕和输卵管堵塞性不孕，收效良好，具备临床应用价值。
显然，根据本发明的上述内容，按照本领域的普通技术知识和惯用手段，在不脱离本发明上述基本技术思想前提下，还可以做出其它多种形式的修改、替换或变更。
以下通过实施例形式的具体实施方式，对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。
具体实施方式
实施例1、本发明药物的制备
配方：盐菟丝子15份、续断片15份、桑寄生15份、桂枝10份、大枣15份、白芍15份、炙甘草8份、威灵仙10份、王不留行10份、丝瓜络10份、丹参15份、巴戟天10份。
制备方法：按配比称取原料，加10倍量水煎煮提取二次，每次提取1小时，煎液过滤，合并滤液，即得。
实施例2、本发明药物的制备
配方：盐菟丝子10份、续断片10份、桑寄生15份、桂枝5份、大枣10份、白芍10份、炙甘草4份、威灵仙5份、王不留行5份、丝瓜络5份、丹参10份、巴戟天5份。
制备方法：按配比称取原料，加8倍量水煎煮提取二次，每次提取1小时，煎液过滤，合并滤液，即得。
实施例3、本发明药物的制备
配方：盐菟丝子20份、续断片20份、桑寄生20份、桂枝15份、大枣20份、白芍20份、炙甘草12份、威灵仙10份、王不留行10份、丝瓜络10份、丹参20份、巴戟天15份。
制备方法：按配比称取原料，加20倍量水煎煮提取二次，每次提取1小时，煎液过滤，合并滤液，即得。
以下通过试验例来说明本发明的有益效果。
试验例1本发明药物组合物治疗排卵障碍性不孕
1资料与方法
1.1一般资料
收集2020年01月01日至2021年06月30日成都中医药大学附属医院妇科诊断为排卵障碍性不孕患者93例，根据随机数字表进行分为3组，试验组30例、对照组31例，对比组32例，三组患者治疗前年龄、性别、病程等方面比较差异无统计学意义(P＞0.05)，具有可比性。
1.2药物及制备
试验药物：盐菟丝子15g、续断片15g、桑寄生15g、桂枝10g、大枣15g、白芍15g、炙甘草8g、威灵仙10g、王不留行10g、丝瓜络10g、丹参15g、巴戟天10g，加水1500ml，浓煎至80～100ml,置于灌肠袋内。
对照组药物：克罗米芬+注射用绒促性素；
对比组：盐菟丝子10份、续断片10份、桑寄生10份、桂枝10份、大枣15份、白芍15份、炙甘草8份、巴戟天10份；制备方法同试验药物。
1.3诊断标准
1.3.1西医诊断标准
(1)生育期女性，性生活正常，月经周期正常，男方生殖功能正常，未避孕一年未孕者；
(2)BBT：呈单向型
(3)宫颈粘液结晶：无椭圆体出现
(4)内膜检查：经前6天或月经来潮后6小时内，内膜检查无典型分泌期变化
(5)卵泡监测：B超连续监测卵泡，有成熟卵泡而无排卵征象，或排卵期优势卵泡平均直径<18mm
(6)血清、尿孕酮值低于黄体期水平
以上六项中在第一项的基础上，同时符合(2)—(6)项中任意两项即可诊断为排卵障碍性不孕。
1.3.2中医诊断标准
主症：①婚久不孕，②月经不调
次症：月经量少，月经后期，闭经，经色紫暗，有血块，舌黯或有瘀点，苔薄白，脉弦或细涩。
具备两项主症，同时具备兼症中任意一项，即可诊断
1.4入选病例标准
符合排卵障碍性不孕诊断标准，同意接受治疗组、对照组或对比组治疗，并自愿签署知情同意书，配合课题组人员试验者。
1.5治疗方法
月经干净开始至下次月经来潮前、3个月经周期为一疗程、本组治疗一疗程。使用前将药温加热至在37～40℃、临睡前侧卧位、将肛管插入肛门约15～20cm(中位保留灌肠)，打开开关、将药液缓慢注入直肠、保留在直肠内2h以上，每晚一次。月经周期第9天开始监测排卵指导受孕，没有获得妊娠者下次月经干净后重复。
试验组及对比组分别使用相应的药物。
对照组接受常规西药治疗，在月经第5天开始，克罗米芬，口服，50mg/次，1次/天，持续5天，待卵泡成熟，注射用绒促性素8000U，肌肉注射1次。
1.6疗效评价
参照国家卫生部颁布的《中药新药临床研究指导原则》及国家中医药管理局颁布的《中医病证诊断疗效标准》的相关内容拟定。
痊愈：成功妊娠，BBT双向，月经恢复正常，临床症状基本好转。
显效：治疗期间超声检测有成熟卵泡并排卵，患者基础体温在三个月经周期中出现一个或一个以上双向或出现不典型双向，治疗后月经周期基本正常(<40天)，临床症状好转。
有效：超声检测无排卵未见优势卵泡，最大卵泡直径治疗前增大5mm以上或发现有卵泡发育，治疗后月经情况有所改善(3个月内来潮一次)，临床症状有一定程度改善。
无效：治疗后月经周期无改善，或超声检测未见卵泡发育现象，或最大卵泡直径较治疗前无增大，BBT单相，临床症状无明显改善。
1.7统计学方法
采用SPSS17.0统计分析软件，计数资料以[例(％)]表示，数据比较采用x检验，等级资料比较采用秩合检验，计量资料以表示，数据比较采用t检验，P<0.05为差异有统计学意义
2结果
表1.本发明药物组合物的临床疗效结果
| 组别 | 例数 | 痊愈(例) | 显效(例) | 有效(例) | 无效(例) | 有效率(％) |
| 试验组 | 30 | 5 | 14 | 8 | 3 | 90％ |
| 对照组 | 31 | 6 | 13 | 7 | 4 | 87.1％ |
| 对比组 | 32 | 3 | 10 | 14 | 5 | 84％ |
试验结果说明：治疗组与对照组有效率相近，治疗组的痊愈及显效病例数和总有效率均显著高于对比组(P<0.05)，说明本发明药物组合物能有效治疗排卵障碍性不孕。
试验例2本发明药物组合物治疗输卵管堵塞性不孕
1资料与方法
1.1一般资料
收集2019年06月01日至2021年06月30日成都中医药大学附属医院妇科诊断为输卵管堵塞性不孕患者89例，根据随机数字表进行分为3组，试验组30例、对照组29例，对比组30例，三组患者治疗前年龄、性别、病程等方面比较差异无统计学意义(P＞0.05)，具有可比性。
1.2药物及制备
试验药物：盐菟丝子15g、续断片15g、桑寄生15g、桂枝10g、大枣15g、白芍15g、炙甘草8g、威灵仙10g、王不留行10g、丝瓜络10g、丹参15g、巴戟天10g，加水1500ml,浓煎至80～100ml,置于灌肠袋内。
对照组药物：来源于经典名方少腹逐瘀汤：小茴香10g、干姜6克、延胡索15克、没药6克、当归10克、川芎10克、肉桂5克、赤芍10克、蒲黄15克、五灵脂10克；制备方法同试验药物；
对比组：盐菟丝子10份、续断片10份、桑寄生10份、桂枝10份、大枣15份、白芍15份、炙甘草8份、巴戟天10份；制备方法同试验药物。
1.3诊断标准
1.3.1西医诊断标准
(1)生育期女性，性生活正常，月经周期正常，男方生殖功能正常，未避孕一年未孕者；
(2)输卵管造影显示单侧或双侧间质部堵塞，堵塞侧输卵管全部不显影。具备此两项便可成立诊断。
1.3.2中医诊断标准
主症：婚久不孕，月经周期正常。
次症：经来腹痛，经量多少不一，经色紫暗，有血块，舌黯或有瘀点，苔薄白，脉弦或细涩。
具备主症2项+次症2项，即可诊断。
1.4入选病例标准
符合输卵管阻塞性不孕诊断标准，同意接受治疗组、对照组或对比组治疗，并自愿签署知情同意书，配合课题组人员试验者。
1.5治疗方法
月经干净7天内行宫腹腔镜术，术后7天开始使用中药直肠滴入治疗，经期停药，连续治疗3个月经周期，3个月经周期后开始试孕。
中药灌肠方法：使用前将药温加热至在37～40℃、临睡前侧卧位、将肛管插入肛门约15～20cm(中位保留灌肠)，打开开关、将药液缓慢注入直肠、保留在直肠内2h以上，每晚一次。
试验组、对照组及对比组分别使用相应的药物。
1.6疗效评价
参照《中药新药临床研究指导原则》
痊愈:一年内正常妊娠，临床体征完全消失，或HSG显示输卵管完全通畅有效:一年内未妊娠，患者临床体征好转，或HSG显示输卵管通畅度改善无效:未妊娠，患者临床体征无改善或加重，或HSG显示输卵管无变化1.7统计学方法
采用SPSS17.0统计分析软件，计数资料以[例(％)]表示，数据比较采用χ2检验，等级资料比较采用秩合检验，计量资料以表示，数据比较采用t检验，P<0.05为差异有统计学意义
2结果
表2.本发明药物组合物的临床疗效结果
| 组别 | 例数 | 痊愈(例) | 有效(例) | 无效(例) | 有效率(％) |
| 试验组 | 30 | 15 | 13 | 2 | 93.3％ |
| 对照组 | 29 | 10 | 12 | 7 | 75.9％ |
| 对比组 | 30 | 9 | 14 | 7 | 70％ |
试验结果说明：治疗组的痊愈病例数和总有效率均显著高于对照组及对比组(P<0.05)，说明本发明药物组合物能有效治疗输卵管堵塞性不孕。
综上，本发明组合物制成的灌肠液，通过直肠吸收，避免了肝肠循环，疗效快，副作用少，经临床试验证明，其能够促进输卵管功能的康复，提升卵巢功能，治疗排卵障碍性不孕和输卵管堵塞性不孕，收效良好，具备临床应用价值。
Claims (8)
1.一种治疗排卵障碍性不孕和输卵管堵塞性不孕的中药组合物，其特征在于：它是由下述重量配比的原料制备而成的外用制剂：
盐菟丝子10~20份、续断片10~20份、桑寄生15~20份、桂枝5~15份、大枣10~20份、白芍10~20份、炙甘草4~12份、威灵仙5~10份、王不留行5~10份、丝瓜络5~10份、丹参10~20份、巴戟天5~15份。
2.根据权利要求1所述的中药组合物，其特征在于：它是由下述重量配比的原料制备而成的外用制剂：
盐菟丝子15份、续断片15份、桑寄生15份、桂枝10份、大枣15份、白芍15份、炙甘草8份、威灵仙10份、王不留行10份、丝瓜络10份、丹参15份、巴戟天10份。
3.根据权利要求1所述的中药组合物，其特征在于：它是由原料药的药粉、或原料药的水或有机溶剂提取物为活性成分，加入药品上可接受的辅料制备而成的外用制剂。
4.根据权利要求3所述的中药组合物，其特征在于：所述外用制剂为颗粒剂、散剂、丸剂或溶液剂。
5.根据权利要求4所述的中药组合物，其特征在于：所述溶液剂为灌肠溶液。
6.权利要求1~5任一项所述中药组合物的制备方法，其特征在于：它包括以下步骤：
（1）按照权利要求1所述配比称取原料药；
（2）原料药研为粉末，或原料药的水或有机溶剂提取液，加入药品上常用的辅料，即得。
7.权利要求1~5任一项所述的组合物在制备治疗排卵障碍性不孕的药物中的用途。
8.权利要求1~5任一项所述的组合物在制备治疗输卵管堵塞性不孕的药物中的用途。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111177024.0A CN115463177B (zh) | 2021-10-09 | 2021-10-09 | 一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111177024.0A CN115463177B (zh) | 2021-10-09 | 2021-10-09 | 一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115463177A CN115463177A (zh) | 2022-12-13 |
| CN115463177B true CN115463177B (zh) | 2023-11-17 |
Family
ID=84363403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111177024.0A Active CN115463177B (zh) | 2021-10-09 | 2021-10-09 | 一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115463177B (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705626A (zh) * | 2013-12-27 | 2014-04-09 | 柳州市工人医院 | 一种辅助治疗输卵管阻塞性不孕的中药组合物及其制备方法 |
| CN104721335A (zh) * | 2015-04-08 | 2015-06-24 | 殷晓燕 | 一种治疗卵泡囊肿的中药组合物 |
| CN105920221A (zh) * | 2016-04-28 | 2016-09-07 | 西南医科大学附属中医医院 | 一种治疗排卵障碍性不孕症的药物组合物及其制备方法和用途 |
| CN111298085A (zh) * | 2020-03-30 | 2020-06-19 | 河南省伟仲和中医中药研究院有限公司 | 一种补气养血、通经活络的中药组合物及制备方法 |
| CN112618644A (zh) * | 2020-12-25 | 2021-04-09 | 李宛静 | 一种治疗卵巢储备功能下降的中药复方组合物及其制备方法 |
-
2021
- 2021-10-09 CN CN202111177024.0A patent/CN115463177B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705626A (zh) * | 2013-12-27 | 2014-04-09 | 柳州市工人医院 | 一种辅助治疗输卵管阻塞性不孕的中药组合物及其制备方法 |
| CN104721335A (zh) * | 2015-04-08 | 2015-06-24 | 殷晓燕 | 一种治疗卵泡囊肿的中药组合物 |
| CN105920221A (zh) * | 2016-04-28 | 2016-09-07 | 西南医科大学附属中医医院 | 一种治疗排卵障碍性不孕症的药物组合物及其制备方法和用途 |
| CN111298085A (zh) * | 2020-03-30 | 2020-06-19 | 河南省伟仲和中医中药研究院有限公司 | 一种补气养血、通经活络的中药组合物及制备方法 |
| CN112618644A (zh) * | 2020-12-25 | 2021-04-09 | 李宛静 | 一种治疗卵巢储备功能下降的中药复方组合物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115463177A (zh) | 2022-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ried | Chinese herbal medicine for female infertility: an updated meta-analysis | |
| CN100546638C (zh) | 一种治疗女性盆腔炎的中药组合物及其用途 | |
| CN103239554A (zh) | 一种治疗奶牛子宫内膜炎的中药组合物及其制备方法 | |
| CN100446806C (zh) | 新生化口服液及其制备方法 | |
| CN100394936C (zh) | 一种治疗崩漏的药物及其制备方法 | |
| CN111568987A (zh) | 一种治疗排卵障碍性不孕症的药物 | |
| CN103638262B (zh) | 妇科止血灵胶囊 | |
| CN102133376A (zh) | 一种调理子宫肌瘤的中草药配方 | |
| CN102078565B (zh) | 一种治疗异位妊娠的中药制剂 | |
| CN115463177B (zh) | 一种治疗卵巢功能低下和/或者输卵管堵塞的中药组合物 | |
| CN102552836A (zh) | 用于避孕和坠胎的中药组合物其制剂及其制备方法 | |
| CN101249193B (zh) | 一种治疗妇科出血性疾病的中药组合物 | |
| CN104147530A (zh) | 一种治疗异位妊娠的药物及其应用 | |
| CN105943758B (zh) | 一种治疗不孕症的中药组合物及其应用 | |
| CN105079633B (zh) | 一种逐瘀活血、消癥散结的中药组合物 | |
| CN103585573A (zh) | 一种用于治疗子宫肌瘤的内服药物 | |
| CN103611027B (zh) | 一种临床预防、护理和治疗滴虫性阴道炎的药物组合物 | |
| Cui et al. | Prophylactic strategy with herbal remedy to reduce puerperal metritis risk in dairy cows: A randomized clinical trial | |
| CN102247505A (zh) | 一种治疗经产母牛屡配不孕症的中药组合物及治疗方法 | |
| CN111905002B (zh) | 一种具有治疗盆腔炎性疾病后遗症的中药制剂及其制备方法与应用 | |
| CN110812463A (zh) | 一种治疗盆腔炎的中药灌肠药剂及其制备方法 | |
| CN104547396A (zh) | 一种治疗月经后期的中药组合物 | |
| CN113491739B (zh) | 治疗子宫内膜异位症的止痛消癥散结中药及其制作方法 | |
| CN103751747B (zh) | 一种治疗药物流产后阴道出血症的中药 | |
| CN104644956A (zh) | 一种治疗寒凝血瘀型痛经的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |